CRISPR-Cas Immunity against Phages: Its Effects on the Evolution and Survival of Bacterial Pathogens

1. BikardD, MarraffiniLA (2012) Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages. Curr Opin Immunol 24: 15–20.

2. WestraER, SwartsDC, StaalsRH, JoreMM, BrounsSJ, et al. (2012) The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity. Annu Rev Genet 46: 311–339.

3. WiedenheftB, SternbergSH, DoudnaJA (2012) RNA-guided genetic silencing systems in bacteria and archaea. Nature 482: 331–338.

4. BarrangouR, FremauxC, DeveauH, RichardsM, BoyavalP, et al. (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315: 1709–1712.

5. CadyKC, Bondy-DenomyJ, HeusslerGE, DavidsonAR, O'TooleGA (2012) The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J Bacteriol 194: 5728–5738.

6. BrounsSJ, JoreMM, LundgrenM, WestraER, SlijkhuisRJ, et al. (2008) Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321: 960–964.

7. GarneauJE, DupuisME, VillionM, RomeroDA, BarrangouR, et al. (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468: 67–71.

8. DatsenkoKA, PougachK, TikhonovA, WannerBL, SeverinovK, et al. (2012) Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun 3: 945.

9. YosefI, GorenMG, QimronU (2012) Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res 40: 5569–5576.

10. CarteJ, WangR, LiH, TernsRM, TernsMP (2008) Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev 22: 3489–3496.

11. HaurwitzRE, JinekM, WiedenheftB, ZhouK, DoudnaJA (2010) Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 329: 1355–1358.

12. JinekM, ChylinskiK, FonfaraI, HauerM, DoudnaJA, et al. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816–821.

13. WestraER, van ErpPB, KunneT, WongSP, StaalsRH, et al. (2012) CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell 46: 595–605.

14. GrissaI, VergnaudG, PourcelC (2007) The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics 8: 172.

15. ChakrabortyS, SnijdersAP, ChakravortyR, AhmedM, TarekAM, et al. (2010) Comparative network clustering of direct repeats (DRs) and cas genes confirms the possibility of the horizontal transfer of CRISPR locus among bacteria. Mol Phylogenet Evol 56: 878–887.

16. GoddeJS, BickertonA (2006) The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes. J Mol Evol 62: 718–729.

17. BikardD, Hatoum-AslanA, MucidaD, MarraffiniLA (2012) CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe 12: 177–186.

18. FischerS, MaierLK, StollB, BrendelJ, FischerE, et al. (2012) An archaeal immune system can detect multiple Protospacer Adjacent Motifs (PAMs) to target invader DNA. J Biol Chem 287: 33351–33363.

19. GudbergsdottirS, DengL, ChenZ, JensenJV, JensenLR, et al. (2011) Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid genes and protospacers. Mol Microbiol 79: 35–49.

20. JiangW, ManivI, ArainF, WangY, LevinBR, et al. (2013) Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. PLoS Genet 9: e1003844 doi:10.1371/journal.pgen.1003844

21. BrodtA, Lurie-WeinbergerMN, GophnaU (2011) CRISPR loci reveal networks of gene exchange in archaea. Biol Direct 6: 65.

22. HorvathP, Coute-MonvoisinAC, RomeroDA, BoyavalP, FremauxC, et al. (2009) Comparative analysis of CRISPR loci in lactic acid bacteria genomes. Int J Food Microbiol 131: 62–70.

23. SternA, KerenL, WurtzelO, AmitaiG, SorekR (2010) Self-targeting by CRISPR: gene regulation or autoimmunity? Trends Genet 26: 335–340.

24. ThomasCM, NielsenKM (2005) Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nat Rev Microbiol 3: 711–721.

25. ErdmannS, GarrettRA (2012) Selective and hyperactive uptake of foreign DNA by adaptive immune systems of an archaeon via two distinct mechanisms. Mol Microbiol 85: 1044–1056.

26. MarraffiniLA, SontheimerEJ (2008) CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322: 1843–1845.

27. Lopez-SanchezMJ, SauvageE, Da CunhaV, ClermontD, Ratsima HariniainaE, et al. (2012) The highly dynamic CRISPR1 system of Streptococcus agalactiae controls the diversity of its mobilome. Mol Microbiol 85: 1057–1071.

28. ZhangY, HeidrichN, AmpattuBJ, GundersonCW, SeifertHS, et al. (2013) Processing-Independent CRISPR RNAs Limit Natural Transformation in Neisseria meningitidis. Mol Cell 50: 488–503.

29. CroucherNJ, HarrisSR, FraserC, QuailMA, BurtonJ, et al. (2011) Rapid pneumococcal evolution in response to clinical interventions. Science 331: 430–434.

30. WeigelLM, ClewellDB, GillSR, ClarkNC, McDougalLK, et al. (2003) Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302: 1569–1571.

31. BisnoAL, BritoMO, CollinsCM (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3: 191–200.

32. NozawaT, FurukawaN, AikawaC, WatanabeT, HaobamB, et al. (2011) CRISPR inhibition of prophage acquisition in Streptococcus pyogenes. PLoS ONE 6: e19543 doi:10.1371/journal.pone.0019543

33. FuruyaEY, LowyFD (2006) Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol 4: 36–45.

34. GillSR, FoutsDE, ArcherGL, MongodinEF, DeboyRT, et al. (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187: 2426–2438.

35. TouchonM, CharpentierS, PognardD, PicardB, ArletG, et al. (2012) Antibiotic resistance plasmids spread among natural isolates of Escherichia coli in spite of CRISPR elements. Microbiology 158: 2997–3004.

36. GoldingGR, BrydenL, LevettPN, McDonaldRR, WongA, et al. (2010) Livestock-associated methicillin-resistant Staphylococcus aureus sequence type 398 in humans, Canada. Emerg Infect Dis 16: 587–594.

37. HoltDC, HoldenMT, TongSY, Castillo-RamirezS, ClarkeL, et al. (2011) A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol 3: 881–895.

38. PalmerKL, GilmoreMS (2010) Multidrug-resistant enterococci lack CRISPR-cas. mBio 1: e00227–00210.

39. GriffithF (1928) The significance of pneumococcal types. J Hyg 27: 113–159.

40. GundersonFF, CianciottoNP (2013) The CRISPR-associated gene cas2 of Legionella pneumophila is required for intracellular infection of amoebae. mBio 4: e00074–00013.

41. DeltchevaE, ChylinskiK, SharmaCM, GonzalesK, ChaoY, et al. (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471: 602–607.

42. JiangW, BikardD, CoxD, ZhangF, MarraffiniLA (2013) RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31: 233–239.

43. JonesCL, SampsonTR, NakayaHI, PulendranB, WeissDS (2012) Repression of bacterial lipoprotein production by Francisella novicida facilitates evasion of innate immune recognition. Cell Microbiol 14: 1531–1543.

44. SampsonTR, SarojSD, LlewellynAC, TzengYL, WeissDS (2013) A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497: 254–257.

45. SampsonTR, SarojSD, LlewellynAC, TzengYL, WeissDS (2013) Corrigendum: a CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 501: 262.

46. LouwenR, Horst-KreftD, de BoerAG, van der GraafL, de KnegtG, et al. (2013) A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barre syndrome. Eur J Clin Microbiol Infect Dis 32: 207–226.

47. Bondy-DenomyJ, PawlukA, MaxwellKL, DavidsonAR (2013) Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493: 429–432.